Global Ketotifen Fumarate Market Research Report 2022

Ketotifen Fumarate is the fumarate salt of ketotifen, a cycloheptathiophene derivative with anti-allergic activity. Ketotifen selectively blocks histamine (H1) receptors and prevents the typical symptoms caused by histamine release. This agent also interferes with the release of inflammatory mediators from mast cells involved in hypersensitivity reactions, thereby decreasing chemotaxis and activation of eosinophils

Due to the COVID-19 pandemic, the global Ketotifen Fumarate market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Ketotifen Fumarate market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Ketotifen Fumarate landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

0.25mg accounting for % of the Ketotifen Fumarate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Anti-Allergic Agents segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Ketotifen Fumarate include Akorn, Amerisource Health, Apotex, CVS Pharmacy, Kaiser Foundation, Proficient Rx, Remedyrepack, Rugby Laboratories and Walgreens and etc. In terms of revenue, the global 3 largest players have a % market share of Ketotifen Fumarate in 2021.

This report focuses on Ketotifen Fumarate volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ketotifen Fumarate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Ketotifen Fumarate Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.



Segment by Type


0.25mg

0.35mg



Segment by Application


Anti-Allergic Agents

Histamine H1 Antagonists

Antipruritics


By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE



By Company


Akorn

Amerisource Health

Apotex

CVS Pharmacy

Kaiser Foundation

Proficient Rx

Remedyrepack

Rugby Laboratories

Walgreens

Novartis